Atropos Health Co-Founder and CEO Brigham Hyde, Ph.D., highlighted the growing role of agentic AI in healthcare while unveiling the company’s new solution, Evidence Agent. The tool integrates into electronic health records and clinician workflows to generate real-world evidence (RWE) at the point of care. Stanford Health Care has already deployed the technology through its ChatEHR and Microsoft’s Dragon Copilot. Hyde explained that Evidence Agent can produce patient-specific studies in seconds, saying “We fill the gap that exists in literature. We call it the evidence gap. There's just not enough studies. We built a machine to automate the production of high-quality studies.”
The company, a Stanford University spinout founded in 2020, aims to make credible, patient-focused evidence available to all U.S. health systems. “We built the Atropos Evidence Agent with strong guardrails to ensure quality and accuracy,” Hyde said. Through collaborations with Microsoft and academic institutions, Atropos seeks to help clinicians access trustworthy insights faster and improve decision-making in real time.
